首页> 外文期刊>The American Journal of Gastroenterology >Effect of biliary stenting combined with ursodeoxycholic acid and terpene treatment on retained common bile duct stones in elderly patients: a multicenter study.
【24h】

Effect of biliary stenting combined with ursodeoxycholic acid and terpene treatment on retained common bile duct stones in elderly patients: a multicenter study.

机译:一项多中心研究:胆道支架置入结合熊去氧胆酸和萜烯对老年患者保留的胆总管结石的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVES: For frail, elderly patients with large impacted common bile duct (CBD) stones, long-term treatment with biliary stenting provides palliation. Biliary stenting with choleretic agents such as ursodeoxycholic acid (UDCA) and terpene preparations may promote CBD stone size reduction. We studied the effectiveness of biliary stenting combined with UDCA and a terpene preparation as a medical treatment for difficult-to-remove CBD stones in patients older than 65 years in this multicenter, prospective study. METHODS: A total of 28 elderly patients with CBD stones refractory to conventional endoscopic removal, including mechanical lithotripsy, underwent endoscopic placement of a straight 10-F plastic biliary stent. Each patient was administered 600 mg of UDCA and 300 mg of a terpene preparation daily for a mean of 6 months. After 6 months of medication following the initial endoscopic retrograde cholangiopancreatography (ERCP), a second ERCP was performed and endoscopic stone removal was again attempted. Differences in stone size and CBD diameter before and after biliary stenting and medication were compared. The complete stone removal rate after treatment was obtained. RESULTS: The mean size (transverse x longitudinal diameter) of the CBD stones was initially 21.6 x 29.5 mm, and it decreased significantly to 12.2 x 20.1 mm at the second ERCP (P<0.01). The mean CBD diameter measured initially at the cystic duct insertion level was 23.2 mm, and it decreased significantly to 19.5 mm at the second ERCP (P<0.01). After biliary stenting with medication, endoscopic stone removal was successful in 26 of 28 patients (92.8%), with a mean of 1.7 subsequent ERCP sessions. CONCLUSIONS: Endoscopic biliary stenting with a period of combined UDCA and terpene preparation administration seems to be a safe and effective method for retained CBD stones in elderly patients. A prospective study with randomization and a control group is required to confirm these results.
机译:目的:对于胆大的胆总管结石较弱的老年患者,胆道支架置入术的长期治疗可缓解。胆管支架置入诸如熊去氧胆酸(UDCA)和萜烯制剂等霍乱剂可能会促进CBD结石尺寸的减小。在这项多中心,前瞻性研究中,我们研究了胆道支架植入术联合UDCA和萜烯制剂对65岁以上患者难以切除的CBD结石的治疗效果。方法:对28例老年CBD结石患者,包括常规机械内碎石术在内的常规内窥镜手术难以治愈的CBD结石患者,进行了内镜下直接放置10 F塑料胆道支架的治疗。每位患者每天服用600 mg UDCA和300 mg萜烯制剂,平均6个月。最初的内镜逆行胰胆管造影术(ERCP)服药6个月后,再次进行了ERCP,并再次尝试了内镜下结石切除术。比较了胆道支架置入和药物治疗前后结石大小和CBD直径的差异。获得处理后的完全结石去除率。结果:CBD结石的平均大小(横向x纵向直径)最初为21.6 x 29.5 mm,在第二次ERCP时显着下降至12.2 x 20.1 mm(P <0.01)。最初在胆囊管插入水平处测得的平均CBD直径为23.2 mm,在第二次ERCP时显着下降至19.5 mm(P <0.01)。胆道内支架置入药物后,在28例患者中有26例(92.8%)成功地进行了内镜下结石切除术,随后的ERCP平均为1.7次。结论:内镜下胆道支架置入术联合UDCA和萜烯制剂联合给药似乎是一种安全有效的方法,可用于治疗老年患者的CBD结石。需要通过随机分组和对照组进行前瞻性研究,以确认这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号